Does Rallies show 13F holders for TOVX?

Yes. Rallies tracks hedge fund and 13F ownership data for TOVX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TOVX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TOVX. It does not provide personalized investment advice.

TOVX (Theriva Biologics, Inc.) Stock Analysis - Hedge Fund Holdings

Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of May 21, 2026, TOVX trades at $0.30 with a market cap of $13.54M and a P/E ratio of -0.14. TOVX moved +11.05% today. Year to date, TOVX is +24.48%; over the trailing twelve months it is -31.22%. Its 52-week range spans $0.16 to $2.64. Analyst consensus is buy with an average price target of $2.50. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TOVX stock?

Hedge funds tracked by Rallies that own TOVX include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Theriva Biologics, Inc..

TOVX Key Metrics

Key financial metrics for TOVX
Metric	Value
Price	$0.30
Market Cap	$13.54M
P/E Ratio	-0.14
EPS	$-2.08
Dividend Yield	0.05%
52-Week High	$2.64
52-Week Low	$0.16
Volume	166.77K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-23.74M
Gross Margin	0.00%

Top Hedge Funds Holding TOVX

Renaissance Technologies holds 103.71K shares of TOVX, changed +51.38% as of Jun 30, 2024.
Citadel Advisors holds 24.68K shares of TOVX, changed -57.42% as of Mar 31, 2024.
Two Sigma holds 10.12K shares of TOVX, changed -83.42% as of Sep 30, 2024.

Latest TOVX News

Theriva Biologics Posts $2M Q1 Loss, $14.4M Cash and FDA Aligns on Phase 3 — May 5, 2026
Theriva Biologics Secures $38M SYN-020 License, Boosts Cash to $15.2M, Plans Phase 3 PDAC Trial — Mar 12, 2026

Recent TOVX Insider Trades

SHALLCROSS STEVEN A bought 14.00K (~$9.70K) on Jun 7, 2023.
SHALLCROSS STEVEN A bought 26.00K (~$16.45K) on Jun 6, 2023.
SHALLCROSS STEVEN A bought 25.00K (~$26.07K) on Feb 10, 2023.

TOVX Analyst Consensus

2 analysts cover TOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.50.

Common questions about TOVX

Who owns TOVX stock?: Hedge funds tracked by Rallies that own TOVX include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Theriva Biologics, Inc..
Does Rallies show 13F holders for TOVX?: Yes. Rallies tracks hedge fund and 13F ownership data for TOVX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TOVX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TOVX. It does not provide personalized investment advice.